Celltrion
068270.KS
#808
Rank
S$33.01 B
Marketcap
$159.38
Share price
0.73%
Change (1 day)
-1.28%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$3.05 Billion

According to Celltrion 's latest financial reports the company's total liabilities are S$3.05 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$1.71 B-6.78%
2021-12-31S$1.84 B-4.87%
2020-12-31S$1.93 B68.57%
2019-12-31S$1.15 B3.54%
2018-12-31S$1.11 B0.22%
2017-12-31S$1.10 B12.19%
2016-12-31S$0.98 B-12.5%
2015-12-31S$1.12 B-3.95%
2014-12-31S$1.17 B9.76%
2013-12-31S$1.07 B33.18%
2012-12-31S$0.80 B41.81%
2011-12-31S$0.56 B32.14%
2010-12-31S$0.42 B28.66%
2009-12-31S$0.33 B3.66%
2008-12-31S$0.32 B494.14%
2007-12-31S$54.16 M